Atlas Trials

A Study of CNCT19 in the Treatment of Relapsed or Refractory Neurological Autoimmune Diseases

Clinical trial NCT07275736 · RECRUITING

Trial details

NCT number
NCT07275736
Sponsor
Juventas Cell Therapy Ltd.
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Neurological Autoimmune Diseases
Start date
2025-03-01
Primary completion
2027-06-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.